Modulation of major histocompatibility class II protein expression by varicella-zoster virus

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 1900-1907

  Abendroth, Allison ^a   Slobedman, Barry ^a   Lee, Eunice ^a   Mellins, Elizabeth ^a   Wallace, Mark ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; STAT1 PROTEIN; TRANSFERRIN RECEPTOR;

ARTICLE; CELL SURFACE; CHICKENPOX; CONTROLLED STUDY; FIBROBLAST; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN BIOPSY; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELLS, CULTURED; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HLA-DR ANTIGENS; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; JANUS KINASE 2; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0033920384     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.1900-1907.2000     Document Type: Article

References (54)

1. Abendroth, A., and A. M. Arvin. 1999. Varicella-zoster virus immune evasion. Immunol. Rev. 168:143-156.
2. Arvin, A. M., J. H. Kushner, S. Feldman, R. L. Baehner, D. Hammond, and T. C. Merigan. 1982. Human leukocyte interferon for the treatment of varicella in children with cancer. N. Engl. J. Med. 306:761-765.
3. Arvin, A. M., C. M. Koropchak, B. R. Williams, F. C. Grumet, and S. K. Foung. 1986. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154:422-429.
4. Arvin, A. 1995. Varicella-zoster virus, p. 2547-2586. In B. Fields, D. Knipe, and P. Howley (ed.), Fields virology. Raven, New York, N.Y.
5. Arvin, A. 1998. Varicella-zoster virus: virologic and immunologic aspects of persistent infection, p. 183-208. In R. Ahmed and I. Chen (ed.), Persistent viral infections. John Wiley & Sons Ltd., New York, N.Y.
6. Asano, Y., N. Itakura, Y. Hiroishi, S. Hirose, T. Ozaki, K. Kuno, T. Nagai, T. Yazaki, K. Yamanishi, and M. Tukahashi. 1985. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J. Infect. Dis. 152:863-868.
7. Bergen, R. E., M. Sharp, A. Sanchez, A. K. Judd, and A. M. Arvin. 1991. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral Immunol. 4:151-166.
8. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107-113.
9. Buchmeier, N. A., and N. R. Cooper. 1989. Suppression of monocyte functions by human cytomegalovirus. Immunology 66:278-283.
10. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51-58.
11. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.
12. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767.
13. Cohen, J., and S. Straus. 1995. Varicella zoster virus and its replication, p. 2525-2546. In B. Fields, D. Knipe, and P. Howley (ed.), Fields virology. Raven, New York, N.Y.
14. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917-4921.
15. Cooper, E. C., L. K. Vujcic, and G. V. Quinnan, Jr. 1988 Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation. J. Infect. Dis. 158:780-788.
16. Dalal, I., E. Arpaia, H. Dadi, S. Kulkarni, J. Squire, and C. M. Roifman. 1998. Cloning and characterization of the human homolog of mouse Jak2. Blood 91:844-851.
17. Diaz, P. S., S. Smith, E. Hunter, and A. M. Arvin. 1989. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J. Immunol. 142:636-641.
18. Glimcher, L. H., and C. J. Kara. 1912. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.
19. Hayward, A. R., O. Pontesilli, M. Herberger, M. Laszlo, and M. Levin. 1986. Specific lysis of varicella-zoster virus-infected B lymphoblasts by human T cells. J. Virol. 58:179-184.
20. Hayward, A., R. Giller, and M. Levin. 1989. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immun. 2:175-184.
21. Heise, M. T., J. L. Pollock, A. O'Guin, M. L. Barkon, S. Bormley, and H. W. Virgin III. 1998. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I Interferon. Virology 241:331-344.
22. Heise, M. T., M. Connick, and H. W. Virgin III. 1998. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1037-1046.
23. Hickling, J. K., L. K. Borjsiewicz, and J. G. Sissons. 1987. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J. Virol. 61:3463-3469.
24. Hobart, M., V. Ramassar, N. Goes, J. Urmson, and P. F. Halloran. 1997. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260-4269.
25. + human T-cell clones. J. Virol. 66:2664-2669.
26. Jenkins, D. E., R. L. Redman, E. M. Lam, C. Liu, I. Lin, and A. M. Arvin. 1998. Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J. Infect. Dis. 178:940-948.
27. Joseph, J., R. L. Knobler, F. D. Lublin, and M. N. Hart. 1991. Mouse hepatitis virus (MHV-4, JHM) blocks gamma-interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells. J. Neuroimmunol. 33:181-190.
28. Lapierre, L. A., W. Fiers, and J. S. Pober. 1988. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons. J. Exp. Med. 167:794-804.
29. Leonard, G. T., and G. C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25-33.
30. Leonard, G. T., and G. C. Sen. 1997. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J. Virol. 71:5095-5101.
31. Leopardi, R., J. Ilonen, L. Mattila, and A. A. Salmi. 1993. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes. Cell Immunol. 147:388-396.
32. Levine, F., H. Erlich, B. Mach, R. Leach, R. White, and D. Pious. 1985. Deletion mapping of HLA and chromosome 6p genes. Proc. Natl. Acad. Sci. USA 82:3741-3745.
33. Maudsley, D. J., and A. G. Morris. 1988. Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line. J. Exp. Med. 167: 706-711.
34. Maudsley, D. J., and A. G. Morris. 1989. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. II. Effects on class II antigen expression. Immunology 67:26-31.
35. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
36. Mikloska, Z., A. M. Kesson, M. E. Penfold, and A. L. Cunningham. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 173:7-17.
37. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. Waldman, and D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
38. Miller, D. M., and D. D. Sedmak. 1999. Viral effects on antigen processing. Curr. Opin. Immunol. 11:94-99.
39. Neefjes, J. J., and F. Momburg. 1993. Cell biology of antigen presentation. Curr. Opin. Immunol. 5:27-34.
40. Perera, L. P., J. D. Mosca, M. Sadeghi-Zadeh, W. T. Ruyechan, and J. Hay. 1992. The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology 191:346-354.
41. Petit, A. J., F. G. Terpstra, and F. Miedema. 1987. Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J. Clin. Investig. 79:1883-1889.
42. Pieters, J. 1997. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9:89-96.
43. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 160:233-240.
44. Pober, J. S., T. Collins, M. A. Gimbrone, Jr., R. S. Cotran, J. D. Gitlin, W. Fiers, C. Clayberger, A. M. Krensky, S. J. Burakoff, and C. S. Reiss. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast 1a antigens induced by recombinant immune interferon. Nature 305:726-729.
45. Rinaldo, C. R., Jr. 1994. Modulation of major histocompatibility complex antigen expression by viral infection. Am. J. Pathol. 144:637-650.
46. Scholz, M., A. Hamann, R. A. Blaheta, M. K. Auth, A. Encke, and B. H. Markus. 1992. Cytomegalovirus-and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum. Immunol. 35:230-238.
47. Sedmak, D. D., A. M. Guglielmo, D. A. Knight, D. J. Birmingham, E. H. Huang, and W. J. Waldman. 1994. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am. J. Pathol. 144:683-692.
48. Sedmak, D. D., S. Chaiwiriyakul, D. A. Knight, and W. J. Waldmann. 1995. The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells. Arch. Virol. 140:111-126.
49. Sharp, M., K. Terada, A. Wilson, S. Nader, P. E. Kinchington, W. T. Ruyechan, J. Hay, and A. M. Arvin. 1992. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852-858.
50. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Graspierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109.
51. Wallace, M. R., I. Woelfl, W. A. Bowler, P. E. Olson, N. B. Murray, S. K. Brodine, E. C. Oldfield III, and A. M. Arvin. 1994. Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella. J. Med. Virol. 43:69-71.
52. Yokosawa, N., T. Kubota, and N. Fujii. 1998. Poor induction of interferon-induced 2′,5′-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1 alpha. Arch. Virol. 143:1985-1992.
53. York, I. A., C. Roop, D. W. Andrews, S. R. Riddell, F. L. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.
54. Zhang, Y., M. Cosyns, M. J. Levin, and A. R. Hayward. 1994. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98:128-133.